Gotham Asset Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $54.7M | Buy |
298,437
+21,628
| +8% | +$3.99M | 0.17% | 83 |
|
|
2025
Q4 | $48.7M | Buy |
276,809
+6,311
| +2% | +$1.03M | 0.18% | 65 |
|
|
2025
Q3 | $37.9M | Buy |
270,498
+107,009
| +65% | +$14.5M | 0.17% | 89 |
|
|
2025
Q2 | $20.5M | Buy |
163,489
+64,261
| +65% | +$8.01M | 0.12% | 185 |
|
|
2025
Q1 | $13.6M | Buy |
99,228
+9,602
| +11% | +$1.37M | 0.11% | 238 |
|
|
2024
Q4 | $13.7M | Buy |
89,626
+47,182
| +111% | +$7.96M | 0.13% | 194 |
|
|
2024
Q3 | $8.23M | Buy |
42,444
+18,887
| +80% | +$3.95M | 0.09% | 354 |
|
|
2024
Q2 | $5.46M | Buy |
+23,557
| New | +$5.12M | 0.07% | 401 |
|
|
2024
Q1 | – | Sell |
-3,684
| Closed | -$953K | – | 1378 |
|
|
2023
Q4 | $953K | Sell |
3,684
-15,766
| -81% | -$3.87M | 0.02% | 808 |
|
|
2023
Q3 | $5M | Sell |
19,450
-11,698
| -38% | -$3.13M | 0.1% | 262 |
|
|
2023
Q2 | $8.87M | Buy |
31,148
+11,274
| +57% | +$3.36M | 0.19% | 83 |
|
|
2023
Q1 | $5.53M | Buy |
19,874
+1,505
| +8% | +$416K | 0.13% | 167 |
|
|
2022
Q4 | $5.09M | Buy |
18,369
+7,253
| +65% | +$2.05M | 0.14% | 161 |
|
|
2022
Q3 | $2.97M | Sell |
11,116
-5,031
| -31% | -$1.07M | 0.09% | 272 |
|
|
2022
Q2 | $3.29M | Sell |
16,147
-9,092
| -36% | -$1.86M | 0.11% | 236 |
|
|
2022
Q1 | $5.32M | Buy |
25,239
+15,155
| +150% | +$3.3M | 0.16% | 157 |
|
|
2021
Q4 | $2.42M | Sell |
10,084
-3,658
| -27% | -$941K | 0.08% | 306 |
|
|
2021
Q3 | $3.89M | Buy |
13,742
+10,832
| +372% | +$3.55M | 0.16% | 185 |
|
|
2021
Q2 | $1.01M | Sell |
2,910
-11,914
| -80% | -$3.61M | 0.04% | 479 |
|
|
2021
Q1 | $4.15M | Sell |
14,824
-8,184
| -36% | -$2.21M | 0.19% | 162 |
|
|
2020
Q4 | $5.63M | Sell |
23,008
-8,035
| -26% | -$2.07M | 0.19% | 164 |
|
|
2020
Q3 | $8.81M | Sell |
31,043
-68,839
| -69% | -$19.2M | 0.28% | 101 |
|
|
2020
Q2 | $26.7M | Sell |
99,882
-34,093
| -25% | -$10.2M | 0.8% | 13 |
|
|
2020
Q1 | $42.4M | Sell |
133,975
-25,791
| -16% | -$7.83M | 1.18% | 2 |
|
|
2019
Q4 | $47.4M | Sell |
159,766
-15,261
| -9% | -$4.23M | 0.87% | 10 |
|
|
2019
Q3 | $40.8M | Buy |
175,027
+19,741
| +13% | +$4.6M | 0.72% | 24 |
|
|
2019
Q2 | $36.3M | Buy |
155,286
+4,034
| +3% | +$931K | 0.58% | 27 |
|
|
2019
Q1 | $35.8M | Buy |
151,252
+44,817
| +42% | +$14.1M | 0.52% | 37 |
|
|
2018
Q4 | $32M | Buy |
106,435
+27,164
| +34% | +$8.67M | 0.5% | 41 |
|
|
2018
Q3 | $28M | Sell |
79,271
-5,836
| -7% | -$2.01M | 0.39% | 66 |
|
|
2018
Q2 | $24.7M | Sell |
85,107
-26,694
| -24% | -$7.5M | 0.36% | 80 |
|
|
2018
Q1 | $30.6M | Buy |
111,801
+23,927
| +27% | +$7.43M | 0.43% | 57 |
|
|
2017
Q4 | $28M | Buy |
87,874
+24,835
| +39% | +$7.97M | 0.41% | 54 |
|
|
2017
Q3 | $19.7M | Sell |
63,039
-99,425
| -61% | -$29.4M | 0.29% | 97 |
|
|
2017
Q2 | $44.1M | Sell |
162,464
-112,996
| -41% | -$29.9M | 0.62% | 20 |
|
|
2017
Q1 | $75.3M | Buy |
275,460
+35,149
| +15% | +$9.94M | 0.96% | 5 |
|
|
2016
Q4 | $68.1M | Sell |
240,311
-5,157
| -2% | -$1.53M | 0.88% | 7 |
|
|
2016
Q3 | $76.8M | Sell |
245,468
-122,627
| -33% | -$36.3M | 1% | 2 |
|
|
2016
Q2 | $89M | Buy |
368,095
+69,422
| +23% | +$18.3M | 1.07% | 1 |
|
|
2016
Q1 | $77.8M | Buy |
298,673
+214,096
| +253% | +$56.6M | 0.87% | 5 |
|
|
2015
Q4 | $25.9M | Buy |
84,577
+75,167
| +799% | +$21.6M | 0.28% | 120 |
|
|
2015
Q3 | $2.75M | Buy |
+9,410
| New | +$3.11M | 0.03% | 506 |
|
|
2015
Q1 | – | Sell |
-5,012
| Closed | -$1.7M | – | 908 |
|
|
2014
Q4 | $1.7M | Sell |
5,012
-26,379
| -84% | -$8.53M | 0.01% | 535 |
|
|
2014
Q3 | $10.4M | Buy |
+31,391
| New | +$10.4M | 0.1% | 287 |
|
|
2014
Q2 | – | Sell |
-3,931
| Closed | -$1.2M | – | 993 |
|
|
2014
Q1 | $1.2M | Buy |
+3,931
| New | +$1.25M | 0.02% | 620 |
|
Other funds holding BIIB
VCM
VPM
Gotham Asset Management's BIIB Position: Q1 2026 in Review
Gotham Asset Management increased its Biogen (BIIB) stake by 7.8% in Q1 2026, buying an estimated $3.99M and bringing the position to 298,437 shares worth $54.7M. The position accounts for 0.17% of the portfolio, ranked #83.
Gotham Asset Management first reported a position in BIIB in Q1 2014 and has held it in 45 quarters since. The position peaked at $89M in Q2 2016. 1,004 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Gotham Asset Management held 298,437 shares of Biogen worth $54.7M as of Q1 2026.
- Gotham Asset Management bought 21,628 Biogen shares in Q1 2026, an estimated $3.99M.
- Biogen made up 0.17% of Gotham Asset Management's portfolio in Q1 2026, its #83 holding.
- Gotham Asset Management first reported a position in Biogen in Q1 2014 and has held it in 45 quarters since.
- Gotham Asset Management's Biogen position peaked at $89M in Q2 2016.
- 1,004 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Gotham Asset Management's 13F filing for Q1 2026, filed 15 May 2026.